← Eichor
Condition: Common Wart Synced from ClinicalTrials.gov · July 27, 2026

Recruiting studies: Common Wart

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05027776
Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatmen
Phase 4 · 18 location(s) · Labo'Life · NCT03977753
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
Phase 4 · 2 location(s) · Riphah International University · NCT07448844
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Phase 2 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT06756269
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Phase N/A · 2 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT05371353
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Phase 3 · 6 location(s) · Verrica Pharmaceuticals Inc. · NCT07246590
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Phase 3 · 4 location(s) · Verrica Pharmaceuticals Inc. · NCT07457918
Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart
NA · 1 location(s) · Mazandaran University of Medical Sciences · NCT06737406
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.